Mirimus
Biotechnology Research • 
Brooklyn, New York, United States • 51-100 Employees
Company overview
| Headquarters | 760 Parkside Ave, Brooklyn, New York 11226, US |
| Phone number | +18336474687 |
| Website | |
| SIC | 873 |
| Keywords | Rna Interference, Crispr, Transgenic Mice, Drug Discovery Tools, Shrna Technology, Covid-19, Pool Testing |
| Founded | 2010 |
| Employees | 51-100 |
| Socials |
Key Contacts at Mirimus
Eduardo J. Garcia Reino
Director Of Translational Research
Gabriella Pollonini
Director Of Laboratory Operations
James Connolly
Vp Of Sales
Amy Sticco
Executive Assistant To Chief Executive Officer
Giuseppe Maria De Peppo
Director
Louis Schure
Director, Business Development
Mirimus Mirimus1
Director
Daniel Neumann
Associate Director Of Operations
Mirimus Email Formats
Mirimus uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@methodisthealthsystem.org), used 37.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@methodisthealthsystem.org | 37.5% |
{first name}.{last name} | john.doe@methodisthealthsystem.org | 25% |
{last name} | doe@methodisthealthsystem.org | 25% |
{first name} | john@methodisthealthsystem.org | 12.5% |
About Mirimus
🔬 Diagnostics We build innovative diagnostic and monitoring tools that empower people to make better decisions about their health. 🧬 Drug Discovery We translate early-stage research into customized RNAi and CRISPR Cas9 animal and cell models to accelerate drug development. 💊 Therapeutics We identify and validate new drug targets, unleashing the commercial potential of RNAi to benefit people on a global scale. Established in 2010 to harness the power of RNAi and genetic engineering technologies developed by our founders in the labs of the world’s leading experts at Cold Spring Harbor Laboratory, Howard Hughes Medical Institute, and Harvard Medical School, Mirimus creates innovative research and clinical technologies to address health issues on a global scale. Today, Mirimus markets multiple unique and high-value drug discovery and diagnostic products and services, and is advancing a pipeline of therapeutic candidates in partnership with leading biopharma companies to create novel high-impact health care solutions that benefits society on a global scale. Mirimus’ ability to leverage its cutting-edge science and proprietary technology platforms to rapidly create new, affordable technology and products at scale is core to the way we work. We embrace diversity and creativity and have a proven track record of innovative problem solving—which led to our recognition as a $1M grand prize winner of the XPRIZE competition by developing a radically affordable, rapid, non-invasive methodology for mass COVID-19 testing—driving us to make better drugs and detect disease earlier. At Mirimus, our ingenuity, respect for our colleagues’ ideas and creativity, executional agility, and a commitment to global health equity combine to create a unique culture of innovation that delivers measurable progress.
Mirimus revenue & valuation
| Annual revenue | $20,000,000 |
| Revenue per employee | $318,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $64,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Mirimus has 23 employees across 6 departments.
Departments
Number of employees
Funding Data
Mirimus has never raised funding before.
Mirimus Tech Stack
Discover the technologies and tools that power Mirimus's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
JavaScript frameworks
JavaScript libraries
Analytics
Miscellaneous
Security
PaaS
Page builders
Analytics
CDN
Canada
Iceland
GermanyFrequently asked questions
4.8
40,000 users
